Bayesian Two-Compartment and Classic Single-Compartment Minimal Models: Comparison on Insulin Modified IVGTT and Effect of Experiment Reduction

Tiziano Callegari, Andrea Caumo, Claudio Cobelli

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Models describing plasma glucose and insulin concentration of an intravenous glucose tolerance test (IVGTT) allow a noninvasive cost-effective approach to estimate important indexes characterizing the efficiency of glucose-insulin control system, i.e., glucose effectiveness (SG) and insulin sensitivity (SI). To overcome some limitations of the classic single compartment minimal model (1CMM) of glucose kinetics, a two-compartment Bayesian minimal model (2CBMM) has been recently proposed for the standard IVGTT. This study aims to assess 2CBMM ability to describe the insulin-modified IVGTT (IM-IVGTT) which is the protocol of choice since it allows to study insulinopenic states. Both a full-length IM-IVGTT (240 min) as well as a reduced version (90 min) of it are studied. Results of the maximum a posteriori identification of IM-IVGTT (240 min) in 13 normals agree with those of standard IVGTT, i.e., a 42% decrease (P <0.002) of SG and a 13% increase (P <0.006) of SI with respect to 1CMM. When identified from IM-IVGTT (90 min), 2CBMM not only provides SG and SI estimates 46% lower (P <0.002) and 41% higher (P <0.002) than 1CMM ones respectively, but also seems to overcome some limitations of the 240 min-based identification that probably arise because the minimal model is unable to properly account for the hyperglycemic hormonal response taking place in the second half of IM-IVGTT.

Original languageEnglish
Pages (from-to)1301-1309
Number of pages9
JournalIEEE Transactions on Biomedical Engineering
Volume50
Issue number12
DOIs
Publication statusPublished - Dec 2003

Fingerprint

Insulin
Glucose
Experiments
Identification (control systems)
Plasmas
Control systems
Kinetics

Keywords

  • Experiment design
  • Glucose kinetics
  • Identification
  • Maximum a posteriori estimation
  • Parameter estimation

ASJC Scopus subject areas

  • Biomedical Engineering

Cite this

Bayesian Two-Compartment and Classic Single-Compartment Minimal Models : Comparison on Insulin Modified IVGTT and Effect of Experiment Reduction. / Callegari, Tiziano; Caumo, Andrea; Cobelli, Claudio.

In: IEEE Transactions on Biomedical Engineering, Vol. 50, No. 12, 12.2003, p. 1301-1309.

Research output: Contribution to journalArticle

@article{30fdab11ba1f43e58669e66186e7788b,
title = "Bayesian Two-Compartment and Classic Single-Compartment Minimal Models: Comparison on Insulin Modified IVGTT and Effect of Experiment Reduction",
abstract = "Models describing plasma glucose and insulin concentration of an intravenous glucose tolerance test (IVGTT) allow a noninvasive cost-effective approach to estimate important indexes characterizing the efficiency of glucose-insulin control system, i.e., glucose effectiveness (SG) and insulin sensitivity (SI). To overcome some limitations of the classic single compartment minimal model (1CMM) of glucose kinetics, a two-compartment Bayesian minimal model (2CBMM) has been recently proposed for the standard IVGTT. This study aims to assess 2CBMM ability to describe the insulin-modified IVGTT (IM-IVGTT) which is the protocol of choice since it allows to study insulinopenic states. Both a full-length IM-IVGTT (240 min) as well as a reduced version (90 min) of it are studied. Results of the maximum a posteriori identification of IM-IVGTT (240 min) in 13 normals agree with those of standard IVGTT, i.e., a 42{\%} decrease (P <0.002) of SG and a 13{\%} increase (P <0.006) of SI with respect to 1CMM. When identified from IM-IVGTT (90 min), 2CBMM not only provides SG and SI estimates 46{\%} lower (P <0.002) and 41{\%} higher (P <0.002) than 1CMM ones respectively, but also seems to overcome some limitations of the 240 min-based identification that probably arise because the minimal model is unable to properly account for the hyperglycemic hormonal response taking place in the second half of IM-IVGTT.",
keywords = "Experiment design, Glucose kinetics, Identification, Maximum a posteriori estimation, Parameter estimation",
author = "Tiziano Callegari and Andrea Caumo and Claudio Cobelli",
year = "2003",
month = "12",
doi = "10.1109/TBME.2003.819850",
language = "English",
volume = "50",
pages = "1301--1309",
journal = "IEEE Transactions on Biomedical Engineering",
issn = "0018-9294",
publisher = "IEEE Computer Society",
number = "12",

}

TY - JOUR

T1 - Bayesian Two-Compartment and Classic Single-Compartment Minimal Models

T2 - Comparison on Insulin Modified IVGTT and Effect of Experiment Reduction

AU - Callegari, Tiziano

AU - Caumo, Andrea

AU - Cobelli, Claudio

PY - 2003/12

Y1 - 2003/12

N2 - Models describing plasma glucose and insulin concentration of an intravenous glucose tolerance test (IVGTT) allow a noninvasive cost-effective approach to estimate important indexes characterizing the efficiency of glucose-insulin control system, i.e., glucose effectiveness (SG) and insulin sensitivity (SI). To overcome some limitations of the classic single compartment minimal model (1CMM) of glucose kinetics, a two-compartment Bayesian minimal model (2CBMM) has been recently proposed for the standard IVGTT. This study aims to assess 2CBMM ability to describe the insulin-modified IVGTT (IM-IVGTT) which is the protocol of choice since it allows to study insulinopenic states. Both a full-length IM-IVGTT (240 min) as well as a reduced version (90 min) of it are studied. Results of the maximum a posteriori identification of IM-IVGTT (240 min) in 13 normals agree with those of standard IVGTT, i.e., a 42% decrease (P <0.002) of SG and a 13% increase (P <0.006) of SI with respect to 1CMM. When identified from IM-IVGTT (90 min), 2CBMM not only provides SG and SI estimates 46% lower (P <0.002) and 41% higher (P <0.002) than 1CMM ones respectively, but also seems to overcome some limitations of the 240 min-based identification that probably arise because the minimal model is unable to properly account for the hyperglycemic hormonal response taking place in the second half of IM-IVGTT.

AB - Models describing plasma glucose and insulin concentration of an intravenous glucose tolerance test (IVGTT) allow a noninvasive cost-effective approach to estimate important indexes characterizing the efficiency of glucose-insulin control system, i.e., glucose effectiveness (SG) and insulin sensitivity (SI). To overcome some limitations of the classic single compartment minimal model (1CMM) of glucose kinetics, a two-compartment Bayesian minimal model (2CBMM) has been recently proposed for the standard IVGTT. This study aims to assess 2CBMM ability to describe the insulin-modified IVGTT (IM-IVGTT) which is the protocol of choice since it allows to study insulinopenic states. Both a full-length IM-IVGTT (240 min) as well as a reduced version (90 min) of it are studied. Results of the maximum a posteriori identification of IM-IVGTT (240 min) in 13 normals agree with those of standard IVGTT, i.e., a 42% decrease (P <0.002) of SG and a 13% increase (P <0.006) of SI with respect to 1CMM. When identified from IM-IVGTT (90 min), 2CBMM not only provides SG and SI estimates 46% lower (P <0.002) and 41% higher (P <0.002) than 1CMM ones respectively, but also seems to overcome some limitations of the 240 min-based identification that probably arise because the minimal model is unable to properly account for the hyperglycemic hormonal response taking place in the second half of IM-IVGTT.

KW - Experiment design

KW - Glucose kinetics

KW - Identification

KW - Maximum a posteriori estimation

KW - Parameter estimation

UR - http://www.scopus.com/inward/record.url?scp=0345356968&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0345356968&partnerID=8YFLogxK

U2 - 10.1109/TBME.2003.819850

DO - 10.1109/TBME.2003.819850

M3 - Article

C2 - 14656059

AN - SCOPUS:0345356968

VL - 50

SP - 1301

EP - 1309

JO - IEEE Transactions on Biomedical Engineering

JF - IEEE Transactions on Biomedical Engineering

SN - 0018-9294

IS - 12

ER -